EXEL – EXELIXIS – a difficult stock to pronounce correctly, but despite that it’s new all time highs today for the molecule therapy drug developer.
This biotech has seen the last 4 quarters with close to 500% growth in sales, a key characteristic in big winning stocks.
Here’s the weekly chart for the biotech recent IPO:
At Trading Room we search for the biggest winning stocks in the market today.
We use market timing, industry group selection, and chart patterns with price and volume analysis.